Abner Garcia-Delgado is an accomplished professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President of Global Operations at CytoImmune Therapeutics, Abner has previously held key leadership roles at CSL Behring, including VP Site Head and Interim VP Site Head, as well as Senior Director of Fractionation. Prior to that, Abner worked at Amgen, where positions included Director of Engineering, Director of Manufacturing, and Senior Manager of Drug Product Process Development Teams. Abner's career began at DuPont as a Manufacturing Manager/Process/Project Engineer, showcasing a strong foundation in engineering and manufacturing processes.